Incyte patents fused pyrimidines, A2A/A2B inhibitors, EP3810610A1
Summary
Incyte patents fused pyrimidines, A2A/A2B inhibitors, EP3810610A1
Source document (simplified)
FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS
Publication EP3810610A1 Kind: A1 Mar 25, 2026
Applicants
Incyte Corporation
Inventors
MCCAMMANT, Matthew S., ZHAO, Le, WANG, Xiaozhao, HAN, Heeoon, WU, Liangxing, YAO, Wenqing, YU, Zhiyong
IPC Classifications
C07D 487/04 20060101AFI20191122BHEP A61P 9/00 20060101ALI20191122BHEP A61P 25/28 20060101ALI20191122BHEP A61P 29/00 20060101ALI20191122BHEP A61P 35/00 20060101ALI20191122BHEP C07D 519/00 20060101ALI20191122BHEP A61K 31/519 20060101ALI20191122BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.